Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2008 3
2009 5
2010 8
2011 4
2012 3
2013 4
2014 3
2015 1
2016 3
2017 2
2018 1
2019 4
2020 5
2021 3
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Multiple myeloma in Korea: past, present, and future perspectives. Experience of the Korean Multiple Myeloma Working Party.
Lee JH, Lee DS, Lee JJ, Chang YH, Jin JY, Jo DY, Bang SM, Kim HJ, Kim JS, Kim K, Eom HS, Min CK, Yoon SS, Kim SH, Suh C, Cho KS; Korean Multiple Myeloma Working Party. Lee JH, et al. Int J Hematol. 2010 Jul;92(1):52-7. doi: 10.1007/s12185-010-0617-6. Epub 2010 Jun 11. Int J Hematol. 2010. PMID: 20544403 Review. No abstract available.
The effectiveness and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world clinical practice: a study of the Korean Multiple Myeloma Working Party (KMMWP-151 study).
Jo JC, Lee HS, Kim K, Lee JJ, Yoon SS, Bang SM, Kim JS, Eom HS, Yoon DH, Lee Y, Shin HJ, Park Y, Lee WS, Do YR, Mun YC, Lee MH, Kim HJ, Kim SH, Kim MK, Lim SN, Cho SH, Park SK, Yi JH, Lee JH, Kim J, Min CK; Korean Multiple Myeloma Working Party (KMMWP). Jo JC, et al. Ann Hematol. 2020 Feb;99(2):309-319. doi: 10.1007/s00277-019-03904-7. Epub 2019 Dec 23. Ann Hematol. 2020. PMID: 31872360 Clinical Trial.
Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-164 study).
Lee HS, Kim K, Kim SJ, Lee JJ, Kim I, Kim JS, Eom HS, Yoon DH, Suh C, Shin HJ, Mun YC, Kim MK, Lim SN, Choi CW, Kang HJ, Yoon SS, Min CK; Korean Multiple Myeloma Working Party (KMMWP). Lee HS, et al. Am J Hematol. 2020 Apr;95(4):413-421. doi: 10.1002/ajh.25726. Epub 2020 Jan 24. Am J Hematol. 2020. PMID: 31919872 Free PMC article. Clinical Trial.
Bendamustine in heavily pre-treated multiple myeloma patients: Results of a retrospective analysis from the Korean Multiple Myeloma Working Party.
Kim SJ, Bang SM, Choi YS, Jo DY, Kim JS, Lee H, Eom HS, Yoon DH, Suh C, Lee JJ, Hong J, Lee JH, Koh Y, Kim K, Yoon SS, Min CK; Korean Multiple Myeloma Working Party. Kim SJ, et al. Blood Res. 2016 Sep;51(3):193-199. doi: 10.5045/br.2016.51.3.193. Epub 2016 Sep 23. Blood Res. 2016. PMID: 27722131 Free PMC article.
Clinical features and survival outcomes in patients with multiple myeloma: analysis of web-based data from the Korean Myeloma Registry.
Kim SJ, Kim K, Kim BS, Jo DY, Kang HJ, Kim JS, Mun YC, Kim CS, Sohn SK, Eom HS, Kwak JY, Shim H, Yoon HJ, Jin JY, Min CK, Shin H, Won JH, Lee JJ, Kwon JH, Joo YD, Do YR, Kim SH, Oh S, Suh C, Lee J, Yoon SS, Kim MK, Bang SM, Ryoo HM, Kim BS, Kim H, Kim HJ, Kim YS, Park CW, Lee GW, Shin HJ, Park SK, Park JS, Kim HY, Lee DS, Lee JH; Korean Multiple Myeloma Working Party. Kim SJ, et al. Acta Haematol. 2009;122(4):200-10. doi: 10.1159/000253027. Epub 2009 Oct 29. Acta Haematol. 2009. PMID: 19887776
Role of thalidomide in previously untreated patients with multiple myeloma.
Musto P, D'Auria F, Pietrantuono G, Bringhen S, Morabito F, Di Raimondo F, Pozzi S, Sacchi S, Boccadoro M, Palumbo A; Gruppo Italiano Malatte Ematologiche dell'Adulto Multiple Myeloma Working Party; Italian Myeloma Network and Gruppo Italiano Studio Linfomi. Musto P, et al. Expert Rev Anticancer Ther. 2008 Oct;8(10):1569-80. doi: 10.1586/14737140.8.10.1569. Expert Rev Anticancer Ther. 2008. PMID: 18925849 Review.
Cyclophosphamide, Bortezomib, and Dexamethasone Consolidation in Patients with Multiple Myeloma after Stem Cell Transplantation: The KMM130 Study.
Jung J, Kim K, Jung SH, Yoon SS, Lee JH, Kim JS, Shin HJ, Bang SM, Sohn SK, Suh C, Yoon DH, Kong SY, Min CK, Eom HS; Korean Multiple Myeloma Working Party. Jung J, et al. Cancer Res Treat. 2023 Apr;55(2):693-703. doi: 10.4143/crt.2022.952. Cancer Res Treat. 2023. PMID: 36397235 Free PMC article. Clinical Trial.
44 results